CAT No: CP26057
CAS No: 80102-26-7
Chemical Name: N-alpha-t-Butyloxycarbonyl-4-methyl-L-phenylalanine
Quick InquiryCustom Peptide SynthesisRegistration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | 80102-26-7;Boc-Phe(4-Me)-OH;N-Boc-4-Methyl-L-phenylalanine;Boc-4-methyl-L-phenylalanine;Boc-L-4-Methylphe;BOC-4-METHY-L-PHENYLALANINE;(2S)-3-(4-methylphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid;MFCD01317027;(S)-2-((tert-butoxycarbonyl)amino)-3-(p-tolyl)propanoic acid;DTXSID50375790;(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(4-methylphenyl)propanoic acid;BOC-P-ME-PHE-OH;L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-4-methyl-;(2S)-2-[(tert-butoxycarbonyl)amino]-3-(4-methylphenyl)propanoic acid;SCHEMBL25672;DTXCID00326818;JYRWNPUFECDJCX-LBPRGKRZSA-N;AKOS015890221;AC-9928;CS-W012284;DS-16139;Boc-Phe(4-Me)-OH, >=98.0% (TLC);A50149;EN300-1589944;(S)-2-TERT-BUTOXYCARBONYLAMINO-3-P-TOLYL-PROPIONIC ACID;(S)-2-(TERT-BUTOXYCARBONYLAMINO)-3-P-TOLYLPROPANOIC ACID;849-042-9; |
M.F/Formula | C15H21NO4 |
M.W/Mr. | 279.33 |
Sequence | Three Letter Code:Boc-Phe(4-Me)-OH |
Size | 1 g;5 g;25 g; |
InChI | InChI=1S/C15H21NO4/c1-10-5-7-11(8-6-10)9-12(13(17)18)16-14(19)20-15(2,3)4/h5-8,12H,9H2,1-4H3,(H,16,19)(H,17,18)/t12-/m0/s1 |
InChI Key | JYRWNPUFECDJCX-LBPRGKRZSA-N |
Canonical SMILES | CC1=CC=C(C=C1)CC(C(=O)O)NC(=O)OC(C)(C)C |
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.